Canary Capital Launches Injective Staked ETF on Nasdaq
New investment vehicle offers traditional brokerage access to Injective blockchain and staking rewards.
1New Nasdaq Investment Vehicle
Canary Capital has officially launched an exchange-traded fund focused on the Injective INJ token. This financial product allows investors to gain exposure to the cryptocurrency directly through traditional brokerage accounts. By utilizing an ETF structure, the firm aims to bridge the gap between conventional finance and specialized blockchain networks for institutional participants.
2Integration of Staking Rewards
A primary feature of this new ETF is the inclusion of potential staking rewards alongside standard price exposure. CEO Steven McClurg noted that investors are increasingly seeking products that offer yield-generating capabilities within familiar market structures. This move follows the firm’s previous digital asset offerings, including their existing XRP and HBAR funds.
3Injective Network Performance Metrics
The Injective network has demonstrated significant activity, processing over 3.13 billion transactions to date. Furthermore, the platform has permanently burned more than 7.27 million INJ tokens, an action valued at approximately $58 million. As of October, the network reported roughly 257,300 monthly active addresses, reflecting a robust and growing user base.
4Focus on Tokenized Assets
Injective is positioning itself as a leader in the tokenization of financial instruments, having already tokenized over $1 billion in assets. The network supports emerging financial applications through specialized infrastructure. This focus on onchain financial markets aligns with the broader institutional goal of bringing traditional asset management onto decentralized blockchain platforms.
5Institutional Adoption and Upgrades
To further support institutional clients, the network introduced Injective Mint and CypherOS. Injective Mint allows for the management of tokenized assets with customizable restrictions, while CypherOS provides privacy-focused infrastructure for confidential trading. Additionally, over $25 million in native USDC stablecoins have been issued on the network to facilitate efficient payment and settlement.
6Market Context and Performance
The launch coincides with a volatile period for the broader cryptocurrency market, which is currently mirroring a tech stock sell-off. Despite this, INJ saw a 5% price increase within 24 hours of the announcement, reaching $8.23. This performance contributes to a 10% gain over the previous week, defying the wider downward market trend.
7Accessibility for Traditional Investors
Eric Chen, co-founder of the Injective Foundation, emphasized that the ETF removes the technical barriers associated with direct cryptocurrency exchange interaction. Investors no longer need to manage blockchain wallets to participate in the ecosystem. This accessibility is expected to broaden the investor base significantly by leveraging existing, trusted brokerage account infrastructures.
8Regulatory and Strategic Implications
The Injective institutional services arm has registered with the SEC as a transfer agent, marking a critical step in regulatory compliance. This development strengthens the network's legitimacy for institutional investors. By connecting mission-driven blockchain technology with traditional market structures, the firm aims to solidify its role in the future of digital finance.
Original article: Bitcoin News — Canary Capital Launches Injective Staked ETF on Nasdaq